Head-to-head · Value Score
CoreAge Rx vs NexLife
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, NexLife a 72. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
NexLife
Grade C · Watch List
Advertised price
From $139/mo
From $139/mo (as low as $119/mo on a 12-month plan, compounded)
The verdict
CoreAge Rx takes it on Value Score, 81 to 72 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. NexLife isn't out of it: Someone comparing month-to-month rates who will read which figure carries the asterisk.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | NexLife |
|---|---|---|
| Value Score | 81 (B) | 72 (C) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | From $139/mo (as low as $119/mo on a 12-month plan, compounded) |
| Save vs brand self-pay | — | — |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | From $139/mo (as low as $119/mo on a 12-month plan, compounded) |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | From $169/mo (compounded) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
NexLife
NexLife is a LegitScript-certified telehealth platform selling compounded semaglutide from $139 and tirzepatide from $169 a month, with a $119 rate available to anyone committing to twelve months.
What's good
- Publishes the month-to-month rate and the twelve-month rate separately rather than showing only the lower one
- The subscription is stated to include provider consultations, the treatment and on-demand medical support with no hidden fees
- All plans are FSA and HSA eligible, with free expedited delivery
- Same-day messaging with the clinical team rather than a ticket queue
The fine print
- The $119 figure that appears across the site needs a twelve-month commitment; the month-to-month rate is $139
- The states served are not publicly disclosed
- GLP-1s sit beside hormone-optimization and longevity lines rather than being the sole focus
- Compounded only — no FDA-approved brand-name route
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to NexLife.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.